OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
Yifat Geffen, Shankara Anand, Yo Akiyama, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3945-3967.e26
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Proteogenomic data and resources for pan-cancer analysis
Yize Li, Yongchao Dou, Felipe da Veiga Leprevost, et al.
Cancer Cell (2023) Vol. 41, Iss. 8, pp. 1397-1406
Open Access | Times Cited: 88

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 59

Pan-cancer proteogenomics connects oncogenic drivers to functional states
Yize Li, Eduard Porta‐Pardo, Collin Tokheim, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3921-3944.e25
Open Access | Times Cited: 55

Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases
Weiyi Yao, Xinting Hu, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18

Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin
Wen-Wei Liang, Rita Jui-Hsien Lu, Reyka G. Jayasinghe, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1567-1585.e7
Open Access | Times Cited: 34

Cancer plasticity in therapy resistance: Mechanisms and novel strategies
Xing Niu, Wenjing Liu, Zhang Yinling, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101114-101114
Closed Access | Times Cited: 16

Comprehensive proteogenomic characterization of rare kidney tumors
Ginny Xiaohe Li, Lijun Chen, Yi Hsiao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101547-101547
Open Access | Times Cited: 13

Unlocking the multifaceted molecular functions and diverse disease implications of lactylation
Fengyang Jing, Jianyun Zhang, Heyu Zhang, et al.
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2024)
Closed Access | Times Cited: 10

Tumor-Intrinsic SIRPA Drives Pyroptosis Evasion in Head and Neck Cancer
Andrew Song, Qian‐Qian Yang, Wenbiao Wang, et al.
Journal of Dental Research (2025)
Closed Access | Times Cited: 1

The present and future of the Cancer Dependency Map
Rand Arafeh, Tsukasa Shibue, Joshua M. Dempster, et al.
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 8

KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
R. Rosell, Jordi Codony‐Servat, Jessica González, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 195, pp. 104228-104228
Open Access | Times Cited: 13

Illuminating function of the understudied druggable kinome
Shawn M. Gomez, Alison D. Axtman, Timothy M. Willson, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 3, pp. 103881-103881
Closed Access | Times Cited: 5

BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer
Zhongdong Xie, Hanbin Lin, Ying Huang, et al.
European Journal of Cancer (2024) Vol. 210, pp. 114278-114278
Closed Access | Times Cited: 5

Functions and mechanisms of non‐histone protein acetylation in plants
Jin Xia, Xiaoshuang Li, Jaime A. Teixeira da Silva, et al.
Journal of Integrative Plant Biology (2024) Vol. 66, Iss. 10, pp. 2087-2101
Open Access | Times Cited: 5

Causal Inference and Annotation of Phosphoproteomics Data in Multi-omics Cancer Studies
Qun Dong, Minjia Tan, Yingchun Zhou, et al.
Molecular & Cellular Proteomics (2025), pp. 100905-100905
Open Access

Pan-cancer secreted proteome and skeletal muscle regulation: insight from a proteogenomic data-driven knowledge base
Traci L. Parry, L. Anne Gilmore, Andy V. Khamoui
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access

Leveraging AI to Explore Structural Contexts of Post-Translational Modifications in Drug Binding
Kirill E. Medvedev, R. Dustin Schaeffer, Nick V. Grishin
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Advancements in proteogenomics for preclinical targeted cancer therapy research
Yuying Suo, Yuanli Song, Yuqiu Wang, et al.
Biophysics Reports (2025) Vol. 11, Iss. 1, pp. 56-56
Open Access

Integrated analysis of proteome and transcriptome profiling reveals pan-cancer-associated pathways and molecular biomarkers
Guo‐sheng Hu, Zaozao Zheng, Yaohui He, et al.
Molecular & Cellular Proteomics (2025), pp. 100919-100919
Open Access

Implication of protein post translational modifications in gastric cancer
Houji Song, Mingze Zhang, Chengwang Guo, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Identifying Sex Differences in Lung Adenocarcinoma Using Multi-Omics Integrative Protein Signaling Networks
Chen Chen, Enakshi Saha, Jonas Fischer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access

Rmzyme: Regulations of RNA Modifying Enzymes in Human
Ruihan Luo, Haixia Xu, Min Qiang, et al.
(2025)
Closed Access

Bimodality in pan-cancer proteomics reveals new opportunities for biomarker discovery
Wen Jiang, Damián E. Bikiel, Jan Zaucha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Page 1 - Next Page

Scroll to top